⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
MDGL News
Madrigal Pharmaceuticals, Inc. Common Stock
Form 8-K
sec.gov
MDGL
Madrigal Pharmaceuticals Reports First-Quarter 2026 Financial Results and Provides Corporate Updates
globenewswire.com
MDGL
Condor Software Launches Advanced Analytics and Dynamic Scenario Suite
prnewswire.com
ACAD
BBIO
MDGL
Madrigal Adds Clinical-Stage siRNA Asset Targeting PNPLA3 to its MASH Pipeline
globenewswire.com
MDGL
Form 8-K
sec.gov
MDGL
Madrigal Pharmaceuticals to Release First-Quarter 2026 Financial Results and Host Webcast on May 6, 2026
globenewswire.com
MDGL
Madrigal Pharmaceuticals Announces Grants of Inducement Awards under Nasdaq Listing Rule 5635(c)(4)
globenewswire.com
MDGL
Madrigal Pharmaceuticals Announces Grants of Inducement Awards under Nasdaq Listing Rule 5635(c)(4)
globenewswire.com
MDGL
The $578 Billion Regenerative Medicine Market Has a Manufacturing Problem. One Company Just Solved the First Step
prnewswire.com
PRME
IOVA
MDGL
DNLI
Advanced Cell-based Therapy Booming the Success for Healthcare Sector
prnewswire.com
PRME
IOVA
MDGL
DNLI